Related Experiment Video
Updated: Jun 7, 2026
03:25
Ginger Moxibustion, A Non-pharmacological Treatment, for Diarrhea in Patients with Chronic Obstructive Pulmonary Disease
Published on: December 27, 2024
[A woman with vomiting and diarrhea]
Joyce Vandeputte1, Harm R Haak
1Máxima Medisch Centrum Veldhoven, afd. Interne Geneeskunde, the Netherlands. j.vandeputte@mmc.nl
Nederlands Tijdschrift Voor Geneeskunde
|October 30, 2010
Summary
A woman on anticoagulant therapy developed a liver subcapsular hematoma, presenting with gastrointestinal symptoms. Prompt blood transfusion and conservative management led to her recovery.
Area of Science:
- Hepatology
- Gastroenterology
- Hematology
Background:
- Anticoagulant therapy is crucial for managing venous thromboembolism (VTE).
- Liver hematomas, particularly subcapsular ones, can arise from various causes, including anticoagulation.
- Gastrointestinal distress can be a symptom of intra-abdominal pathologies.
Observation:
- A 38-year-old female patient presented with a four-day history of vomiting, diarrhea, and abdominal pain.
- The patient was on anticoagulant medication due to a history of VTE.
- Abdominal echography identified a subcapsular liver hematoma.
Findings:
- The patient's symptoms were attributed to a liver subcapsular hematoma.
- The hematoma was successfully managed without surgical intervention.
- Conservative treatment, including blood transfusion, was effective in resolving the condition.
Implications:
- This case highlights the potential risk of liver hematoma in patients using anticoagulants.
- Early diagnosis via imaging is critical for appropriate management.
- Conservative treatment strategies can be successful for liver subcapsular hematomas in select patients.
Related Concept Videos
01:18Bacterial Gastroenteritis
Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
01:25Cholera
Cholera is an acute gastrointestinal disease caused by the Gram-negative bacterium Vibrio cholerae. It is transmitted primarily via the fecal-oral route through the ingestion of contaminated water or food.Vibrio cholerae is a motile, Gram-negative bacterium of the family Vibrionaceae, primarily associated with waterborne outbreaks in areas with inadequate sanitation. Although over 200 serogroups of V. cholerae exist, only O1 and O139 are responsible for epidemic cholera. The O1 serogroup,...
01:22Pathophysiology of Vomiting
Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through interaction...
01:30Bulimia Nervosa
Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
01:17Drugs for Treatment of Diarrhea-Predominant IBS
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
01:07Intestinal Obstruction II: Pathophysiology
Intestinal obstruction triggers a series of physiological responses, starting with gas and fluid accumulation in the bowel segment proximal to the obstruction, leading to distension. This distended intestine compresses the diaphragm, hindering lung expansion and potentially leading to reduced respiratory effort, atelectasis, and pneumonia.To overcome the blockage, the gut intensifies contractions, causing colicky abdominal pain, nausea, and vomiting, which reduces fluid and food intake and...